Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT

Cancer Imaging

Volumn 11, Issue 1, 2011, Pages 179-183

  Kaemmerer, Daniel ^a   Khatib Chahidi, Karl ^a   Baum, Richard Paul ^a   Hörsch, Dieter ^a   Presselt, Norbert ^a   Sänger, Jörg ^b   Kunze, Almut ^b   Hommann, Merten ^a  

^a ZENTRALKLINIK BAD BERKA   (Germany)

^b Laboratory for Pathology and Cytology   (Germany)

Author keywords

Gamma probe detection; Somatostatin receptor PET CT, TTF 1; Typical carcinoids of the lung

Indexed keywords

CHROMOGRANIN A; GALLIUM 68; SOMATOSTATIN RECEPTOR 2; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR CDX2;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONCURRENT INFECTION; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT EXAMINATION; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; ILEUM TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LUNG TUMOR; LYMPH NODE METASTASIS; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; TUMOR DIFFERENTIATION;

AGED; CARCINOID TUMOR; FEMALE; GALLIUM RADIOISOTOPES; HUMANS; ILEAL NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RECEPTORS, SOMATOSTATIN;

EID: 82655185060     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.0035     Document Type: Article

References (11)

1. Gustafsson BI, Kidd M, Chan A, Malfertheiner MV, Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer 2008; 113: 5-21. doi:10.1002/cncr.23542. (Pubitemid 351976381)
2. Du EZ, Goldstraw P, Zacharias J, et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Human Pathol 2004; 35: 825-31. doi:10.1016/j.humpath.2004.02.016. (Pubitemid 38903075)
3. Lin X, Saad RS, Luckasevic TM, Silverman JF, Liu Y. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol 2007; 15: 407-14. (Pubitemid 350307846)
4. Aydin E, Yazici U, Gulgosteren M, et al. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary carcinoid: our institutional experience with 104 patients. Eur J Cardiothorac Surg 39: 549-54. doi:10.1016/j.ejcts.2010.08.010.
5. Ambrosini V, Castellucci P, Rubello D, et al. 68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. Nucl Med Commun 2009; 30: 281-6. doi:10.1097/MNM.0b013e32832999c1.
6. Liu WH, Wang DG. Apoptosis regulating genes in neuroendocrine tumors. Histol Histopathol 2000; 15: 851-9.
7. Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol 2009; 33: 626-32.
8. Adams S, Baum RP. Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors. Q J Nucl Med 2000; 44: 59-67. (Pubitemid 30325954)
9. 68Ga-DOTATOC PET but undetectable by surgical palpation or conventional imaging. Nuklearmedizin 2009; 48: N50-1.
10. Al-Nahhas A, Win Z, Szyszko T, et al. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007; 27: 4087-94.
11. Jindal T, Kumar A, Venkitaraman B, Dutta R, Kumar R. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids. Korean J Internal Med 25: 386-91. doi:10.3904/kjim.2010.25.4.386.